Comparative in-virto activity of Ro 23-6240, a new trifluorinated quinolone
- 1 September 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 20 (3) , 363-372
- https://doi.org/10.1093/jac/20.3.363
Abstract
The in-virto activity of Ro 23-6240, a new quinolone, was tested in comparison with that of other quinolones aginst 486 recent clinical isolates. Ro 23-6240 displayed the typical features of the new quinolones: highest activity against Gram-negative bacilli, MBCs close to the MICs, minimum inoculum effect and rapid killing. Against Gram-negative organisms (Enterobacteriaceae, non-fermenters, Haemophilus influenzae and gonococci) the activity of Ro 23-6240 was between that of ofloxacin and norfloxacin; against staphylococci its activity was between that of ciprofloxacin and ofloxacin, and aginst streptococci it was similar to that of norfloxacin.Keywords
This publication has 7 references indexed in Scilit:
- In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivativeAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of Ro 23-6240, a new fluorinated 4-quinoloneAntimicrobial Agents and Chemotherapy, 1986
- In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolonesAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of A-56619 and A56620, two new aryl-fluoroquinolone antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1986
- In vitro evaluation of A-56619 and A-56620, two new quinolonesAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983
- In vitro and in vivo activity of DL-8280, a new oxazine derivativeAntimicrobial Agents and Chemotherapy, 1982